| abstract |
The present invention describes a compound, or enantiomers, stereoisomers, rotamers, tautomers, racemates or prodrugs of said compound, or salts acceptable for pharmaceutical or solvate use of said compound, or of said prodrug, said compound having the general structure shown in formula (1) (see formula (I)): useful for the treatment or prevention or relief of one or more symptoms of hepatitis C. |